Fast and complete cyclic peptide metabolite detection and characterization by LC-MS

Cyclic peptides have emerged as next-generation therapeutic agents, due to their unique structure and potential biological function. However, the study of cyclic peptide drug metabolism by LC-MS is challenging because these therapeutics typically do not generate high quality and interpretable fragments; and data processing is complex and tedious due to the lack of suitable software tools. This study outlines the streamlined process for analysis of cyclic peptide metabolites utilizing high-resolution QTOF analysis and MetabolitePilot Software. The unbiased data acquisition and automated detection and structural characterization of cyclic peptides will be shown using insulin and atrial natriuretic peptide (ANP) as model compounds in the biological matrix.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Is Mixed Reality on the Horizon for Healthcare?

mantralabsglobal.com

Mixed Reality (MR) also known as “hybrid reality” and “extended reality,” has the potential to change just about every industry, healthcare being no exception. A combination of Virtual Reality (VR), Augmented Reality (AR), and Artificial Intelligence (AI); MR is emerging as a tech to create experiences that blend the real-life environment with digital elements.
Watch Now

High Throughput, Low Volume Subvisible Particle Analysis

Halo Labs

Subvisible particle analysis is a key predictor of protein drug stability and a key formulation, quality metric. However, current methods use large volumes of precious protein solutions and are labor- and time-intensive, making this data inaccessible during late-stage candidate screening or early in formulation. Moreover, regulatory agencies are tightly enforcing subvisible particle content in biopharma formulations at unprecedented levels, making early detection of subvisible particles, like protein aggregates, a key analytical priority.
Watch Now

[Recorded Webinar] RNA Based Therapeutics and Vaccines: Bioprocessing Technology Trends

merckmillipore

According to market research, DNA and RNA therapeutics are growing at 12% CAGR and expected to reach $1.2 billion by 2020. This webinar reviews the current dynamics in the RNA therapeutics/vaccines market and focuses on process development and manufacturing strategies.
Watch Now

How Updates to EU GMP Annex 1 Impact Sterilizing Filtration in Single Use Systems

The recently published revision to Eudralex Vol. 4 Annex 1, clarified current expectations for manufacture of sterile medicinal products in light of improved process understanding and advances in processing technologies.
Watch Now

Spotlight

resources